Dopamine receptors in the basal ganglia: Relevance to parkinson's disease
- 1 January 1993
- journal article
- review article
- Published by Wiley in Movement Disorders
- Vol. 8 (3) , 263-270
- https://doi.org/10.1002/mds.870080303
Abstract
At least five receptors for dopamine (D1–D5) have been recognised from molecular biological studies, and their pharmacological properties and brain localisations have been determined. The D1 and D2 subtypes are the principal subtypes in brain, and their cellular localisations in the caudate nucleus and putamen have been determined. With recent advances in the understanding of basal ganglia neuronal function, these localisation data enable insights into the mode of action of drugs used at present and in the futue to treat Parkinson's disease.Keywords
This publication has 47 references indexed in Scilit:
- Weak Antiparkinsonian Activity of the D1 Agonist C-APB (SKF 82958) and Lack of Synergism With a D2 Agonist in PrimatesClinical Neuropharmacology, 1992
- D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal NeuronsScience, 1990
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Molecular cloning and expression of the gene for a human D1 dopamine receptorNature, 1990
- Disinhibition as a basic process in the expression of striatal functionsTrends in Neurosciences, 1990
- The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neuronesTrends in Neurosciences, 1990
- Role of the mesostriatal dopamine pathwayTrends in Neurosciences, 1990
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- Selective D-1 dopamine receptor agonist treatment of parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987